Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00261443
What this trial is testing

Aripiprazole (Abilify) in Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,270
Large-scale testing (Phase 3)Study completedNCT00237874
What this trial is testing

Aripiprazole Treatment of Prodromal Patients

Who this might be right for
SchizophreniaPsychosis
Yale University 15
Post-approval studies (Phase 4)Study completedNCT00520650
What this trial is testing

Health Evaluation of Abilify Long-term Therapy

Who this might be right for
SchizophreniaSchizoaffective Disorder
Taiwan Otsuka Pharm. Co., Ltd 245
Post-approval studies (Phase 4)Study completedNCT05103410
What this trial is testing

Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy

Who this might be right for
AnesthesiaAnalgesiaHysterotomy
Ain Shams University 80
Testing effectiveness (Phase 2)Study completedNCT04030143
What this trial is testing

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder

Who this might be right for
SchizophreniaBipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 266
Not applicableNot Yet RecruitingNCT07547384
What this trial is testing

Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.

Who this might be right for
Schizophrenia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 116
Post-approval studies (Phase 4)UnknownNCT03883204
What this trial is testing

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up

Who this might be right for
SchizophreniaPsychotic DisordersPsychosis
Fundación Marques de Valdecilla 115
Early research (Phase 1)Study completedNCT00102479
What this trial is testing

Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents

Who this might be right for
SchizophreniaMania
Otsuka Pharmaceutical Development & Commercialization, Inc. 21
Large-scale testing (Phase 3)Study completedNCT00097266
What this trial is testing

Study of Aripiprazole in Patients With Acute Bipolar Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 615
Large-scale testing (Phase 3)Study completedNCT00101569
What this trial is testing

Aripiprazole Oral Acceptability Trial

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 59
Testing effectiveness (Phase 2)Study completedNCT00198055
What this trial is testing

Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.

Who this might be right for
Asperger's DisorderPervasive Developmental Disorder
Indiana University 25
Large-scale testing (Phase 3)Study completedNCT01149655
What this trial is testing

Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 252
Large-scale testing (Phase 3)Study completedNCT00556140
What this trial is testing

The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression

Who this might be right for
Psychotic Depression
Massachusetts General Hospital 16
Large-scale testing (Phase 3)Study completedNCT01617460
What this trial is testing

A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

Who this might be right for
Autistic Disorder
Otsuka Pharmaceutical Co., Ltd. 86
Large-scale testing (Phase 3)Study completedNCT00036348
What this trial is testing

Study of Aripiprazole in Patients With a History of Bipolar Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
Post-approval studies (Phase 4)Study completedNCT00222833
What this trial is testing

The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia

Who this might be right for
OverweightHyperlipidemiaCardiovascular Diseases
University of Pittsburgh 30
Large-scale testing (Phase 3)Study completedNCT00706654
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 937
Early research (Phase 1)Study completedNCT00361790
What this trial is testing

Aripiprazole and Lexapro Drug Interaction Study

Who this might be right for
Healthy
Otsuka Pharmaceutical Development & Commercialization, Inc. 25
Not applicableStudy completedNCT00216723
What this trial is testing

Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

Who this might be right for
SchizophreniaBipolar Disorder
Korea Otsuka Pharmaceutical Co., Ltd. 3,000
Early research (Phase 1)Study completedNCT02088697
What this trial is testing

A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Subjects

Who this might be right for
Healthy Volunteers
Otsuka Pharmaceutical Co., Ltd. 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation